Investigating a Mediterranean diet to slow vision loss in older adults with AMD
Official title: Feasibility Studies for the Future Mediterranean Glucose Lowering Dietfor Vision Extension in AMD (M-GLOVE-AMD)
Funded at Stanford University · NIH-10794815 · Data updated 2026-11-12
This study is looking at whether following a Mediterranean diet can help slow down vision loss from age-related macular degeneration (AMD) in people over 55 who don’t have diabetes and are in the early stages of the condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $265,835 |
| NIH project number | 1R34EY035782-01 |
| Project ID | NIH-10794815 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are non-diabetic individuals aged 55 and older who have been diagnosed with early-stage age-related macular degeneration.
✕Less likely to help
Patients with advanced AMD or those who are diabetic may not benefit from this research.
What this research studies
This research focuses on age-related macular degeneration (AMD), a common cause of vision loss in individuals over 55. It aims to assess the feasibility of a Mediterranean diet, known for its health benefits, in slowing the progression of AMD in non-diabetic patients with early-stage disease. The study will involve dietary interventions to shift participants from a typical Western diet to a low glycemic Mediterranean diet, while also evaluating advanced imaging techniques and potential biomarkers. The ultimate goal is to lay the groundwork for a larger multicenter study comparing this dietary approach to standard dietary practices.
Why it matters
Potential benefit: If successful, this research could provide a cost-effective dietary intervention to help preserve vision in older adults with AMD.
How similar studies have gone: Previous observational studies have suggested that Mediterranean diets may help slow AMD progression, indicating potential success for this dietary approach.
Where this research is happening
-
Stanford University
Stanford, United States Active
Researchers
- Principal investigator: Hartnett, Mary Elizabeth Ruth — Stanford University
- Study coordinator: Hartnett, Mary Elizabeth Ruth
Related research
Other NIH-funded projects on the same topics.
-
Mediterranean low-glycemic diet to protect vision in early AMD
This project will test whether people with early age-related macular degeneration can switch to a Mediterranean-style, low-glycemic diet and whether that change might help slow vision loss.
-
Investigating ways to improve pain management and drug formulation.
This study is all about finding better ways to manage pain by creating new and improved medications, and it’s designed for patients who are looking for effective pain relief options.
-
Improving pain management and treatment through clinical trial readiness and drug formulation.
This study is all about finding better ways to manage pain, so if you're dealing with pain, this research could lead to new treatments that might help you feel better.
-
Automated ABPI for Peripheral Artery Disease: A Pilot Look at Two Devices
This pilot checks if two automated ankle-brachial pressure index devices can reliably detect PAD across symptom levels and after bypass surgery, using patient and clinician feedback for practicality.
-
AI-powered personalized exercise plan for older adults using a wearable app
A wearable-enabled, AI-driven exercise app is tested to see if it’s feasible and acceptable for adults 65+ and whether it can help increase activity, improve mood, and boost quality of life.
-
Behavioral program to help depressed nursing home residents see if it helps
This study tests the InSTILL program to see if it is feasible, satisfactory, and helpful for residents of skilled nursing facilities who have depressive symptoms.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.